Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

GetLS

You Said

"That is how Gartner got his hands on the IP that he is now using to manufacture and sell DR-70."

I didn't see anything in the 8-K that this statement can be a fact you understand.. I do know that in the 8-K ..ProvistaDx has all rights to use DR-70 at no cost to them...Why would William start a company named GCDX to try to get DR-70 for a lung cancer test when He can use it for free from ProvistaDx a company he gave to Angel Investors and is still an Executive VP with Provista DX. That would be a conflict of interest, wouldn't you agree? and silly.. Wolf


You Said

Gartner is still calling it "The Lung Cancer Test" on his website and on Fundable.com. In the PR (link below) he is calling it "The Lung Cancer Test for Early Detection."



You are in correct..William did not get turned down from his "The Lung Cancer Test"..He abandoned it.Please look up Trademark Laws and you will find this to be factual...William is no longer using "The Lung Cancer Test" except in the web page..Which is outdated. The new order us is using an outdated page...If it was updated, William would be using his new Trademark, the one you added in your post..."The Lung Cancer Test for Early Detection tm "



GetSeriousOK Saturday, 10/04/14 09:09:55 AM
Re: dcspka post# 25481
Post # of 25485
The 6K was the money Gartner gave to Radient to get the IP for DR70. Provista had nothing to do with that.

That is how Gartner got his hands on the IP that he is now using to manufacture and sell DR-70. Gartner is still calling it "The Lung Cancer Test" on his website and on Fundable.com. In the PR (link below) he is calling it "The Lung Cancer Test for Early Detection."